Literature DB >> 24453528

Doping and performance enhancing drug use in athletes living in sivas, mid-anatolia: a brief report.

Levent Ozdemir1, Naim Nur1, Ihsan Bagcivan2, Okay Bulut3, Haldun Sümer1, Gündüz Tezeren3.   

Abstract

The aim of this study was to determine the rate of doping and performance enhancing drug use in athletes in Sivas, Turkey, and to analyze the main reasons for the use. This was a cross-sectional study based on a self-report questionnaire. The subjects filled the questionnaires under the supervision of the investigators during interviews. This questionnaire included 24 items describing the population in terms of demographics, sport practice, doping in sport and substance use. Moreover, we assessed the frequency of doping drug use. The number of respondents was 883, of which 433 athletes and 450 healthy non-athletes (control group). The mean age of the total volunteers was 21.8 ± 3.7 yrs. The male and female ratios were 78.2% and 21.8% respectively. Doping and performance enhancing drug usage rate was 8.0% (71cases in 883 subjects). Doping drug use among the athletes was significantly (p < 0.05) higher (14.5%) compared with the non-athletes (1.8%). The agents used were anabolic steroids in 60.5%, l-carnitene in 12.7%, erythropoietin in 5.4%, Na-bicarbonate in 11.3% and creatinine in 14.1% of 71 cases. The reasons for doping use were to have a better body condition in 34 cases (47.9%) and to solve weight (gaining or loosing) problems in 8 (11.3%) cases. Since the potential side effects of doping drugs are not satisfactorily familiar to the most users, the education of athletes on the matter must be a top priority. Key PointsDoping and performance enhancing drug use was 71 (8.0%) in 883 subjects, and it was significantly higher (14.5%) in the athletes compared with the non-athletes (1.8%) in Sivas, Turkey.The rate of athletes who experienced such drugs at least once in their life was 29.0%.The 52.4% of doping and performance enhancing drug users accepted that they were unaware of the drugs full and/or potential side effects.

Entities:  

Keywords:  Drug abuse; sports

Year:  2005        PMID: 24453528      PMCID: PMC3887327     

Source DB:  PubMed          Journal:  J Sports Sci Med        ISSN: 1303-2968            Impact factor:   2.988


  13 in total

Review 1.  Risk factors associated with anabolic-androgenic steroid use among adolescents.

Authors:  M S Bahrke; C E Yesalis; A N Kopstein; J A Stephens
Journal:  Sports Med       Date:  2000-06       Impact factor: 11.136

Review 2.  [Doping in high-level athletes].

Authors:  B Chalchat
Journal:  Ann Pharm Fr       Date:  2002-09

Review 3.  [High-performance society and doping].

Authors:  C L Gallien
Journal:  Ann Pharm Fr       Date:  2002-09

4.  [Doping practices and behaviours among Ivorian soccer players].

Authors:  Cyrille Dah; Pascal Bogui; Jean-Claude Yavo; Issa Gourouza; Soualiho Ouattara; Mustapha Keita
Journal:  Sante       Date:  2002 Jul-Sep

Review 5.  Doping among adolescent athletes.

Authors:  C E Yesalis; M S Bahrke
Journal:  Baillieres Best Pract Res Clin Endocrinol Metab       Date:  2000-03

6.  [Doping: epidemiological studies].

Authors:  P Laure
Journal:  Presse Med       Date:  2000 Jul 8-15       Impact factor: 1.228

7.  Combating drug use in competitive sports. An analysis from the athletes' perspective.

Authors:  H Striegel; G Vollkommer; H-H Dickhuth
Journal:  J Sports Med Phys Fitness       Date:  2002-09       Impact factor: 1.637

Review 8.  [Doping--a medical problem in Denmark?].

Authors:  D B Keld; A K Bendsen
Journal:  Ugeskr Laeger       Date:  1998-08-10

9.  Doping among high school students in Uppsala, Sweden: A presentation of the attitudes, distribution, side effects, and extent of use.

Authors:  A M Kindlundh; D G Isacson; L Berglund; F Nyberg
Journal:  Scand J Soc Med       Date:  1998-03

10.  Estimated prevalence of anabolic steroid use among male high school seniors.

Authors:  W E Buckley; C E Yesalis; K E Friedl; W A Anderson; A L Streit; J E Wright
Journal:  JAMA       Date:  1988-12-16       Impact factor: 56.272

View more
  2 in total

1.  Sport nutrition and doping in tennis: an analysis of athletes' attitudes and knowledge.

Authors:  Miran Kondric; Damir Sekulic; Ognjen Uljevic; Goran Gabrilo; Milan Zvan
Journal:  J Sports Sci Med       Date:  2013-06-01       Impact factor: 2.988

2.  Doping Prevalence in Competitive Sport: Evidence Synthesis with "Best Practice" Recommendations and Reporting Guidelines from the WADA Working Group on Doping Prevalence.

Authors:  John Gleaves; Andrea Petróczi; Dirk Folkerts; Olivier de Hon; Emmanuel Macedo; Martial Saugy; Maarten Cruyff
Journal:  Sports Med       Date:  2021-04-26       Impact factor: 11.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.